Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study.

Javier Martínez-Sanz,Sergio Serrano-Villar,Alfonso Muriel,Lucio J García Fraile,Eva Orviz, Álvaro Mena de Cea,Antoni A Campins,Santiago Moreno

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2023）

引用 4|浏览10

暂无评分

摘要

Switching from TDF to TAF is associated with modest weight gain and increases in total cholesterol and triglycerides, without an impact on the incidence of obesity or metabolic-related clinical events, in this Spanish cohort with a majority White male population.

查看译文

关键词

HIV,metabolic events,switch,tenofovir alafenamide,weight gain

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要